Contact this trialFirst, we need to learn more about you.
Alkylating agents
Short Course Radiation + TASOX for Rectal Cancer
Recruiting1 awardPhase 2
Seattle, Washington
This trial involves treating adults with stage II/III rectal cancer using a combination of radiation, chemotherapy, and surgery. The radiation helps shrink the tumor, the chemotherapy kills additional cancer cells, and the surgery removes the remaining cancer. This approach aims to allow for effective cancer removal while preserving normal functions.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service